Study guide
9.1 Anticipating Pharmacologic Needs
Registered Cardiovascular Invasive Specialist RCIS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current RCIS Exam Facts 1.2 Eligibility Pathways & Documentation 1.3 Examination Matrix & Study Plan
2 Pre-Procedural Room Setup & Sterile Technique
2.1 Procedure & Control Room Setup 2.2 Sterile Technique & Universal Precautions 2.3 Personnel Preparation & Cath Lab Roles
3 Pre-Procedural Patient Preparation & Validation
3.1 Preparing the Patient for Invasive Procedures 3.2 Records, Labs, Allergies & Consent 3.3 Time-Out & Universal Protocol
4 Patient Monitoring & Vascular Access
4.1 Intraprocedural Vital Sign Monitoring 4.2 Arterial & Venous Access Sites 4.3 Ultrasound-Guided Access
5 Coronary Anatomy & Left Heart Catheterization
5.1 Coronary Anatomy & Dominance 5.2 Left Heart Catheterization & Coronary Angiography 5.3 Catheter Shapes & Angiographic Projections 5.4 Left Ventriculography & Aortography
6 Right Heart Catheterization & Hemodynamics
6.1 Right Heart Waveforms & Pressures 6.2 Cardiac Output: Fick & Thermodilution 6.3 Valve Area, Bernoulli & Shunt Calculations 6.4 Endomyocardial Biopsy Support
7 ECG & Intracardiac/Intravascular Imaging
7.1 12-Lead ECG in the Cath Lab 7.2 Intracardiac Echocardiography (ICE) 7.3 IVUS & OCT 7.4 Identifying Structures on Cardiac Ultrasound
8 Physiology Assessment & Radiation Safety
8.1 FFR & iFR Studies 8.2 Radiation Safety & ALARA 8.3 Radiographic Equipment Operation 8.4 Image Acquisition & Interpretation
9 Cath Lab Pharmacology
9.1 Anticipating Pharmacologic Needs 9.2 Recognizing Medication Effects & Adverse Reactions 9.3 Anticoagulation & ACT Targets
10 PCI Fundamentals
10.1 Balloon Angioplasty & Stent Platforms 10.2 Coronary Wiring, Lesion Prep & Flow Grades 10.3 Vascular Closure Devices
11 Chapter 11: Complex Coronary Intervention
11.1 CTO, Atherectomy & Alcohol Septal Ablation 11.2 Cardiac Thrombectomy (Mechanical & Aspiration) 11.3 Distal Protection Devices
12 Device Implants & Temporary Support
12.1 Pacemaker, ICD, CRT & Loop Recorders 12.2 Transvenous Temporary Pacemaker 12.3 Pericardiocentesis Support
13 Mechanical Circulatory Support
13.1 IABP & Impella 13.2 ECMO & LVAD Overview for the Cath Lab
14 Peripheral Vascular Interventions
14.1 Peripheral Interventions 14.2 Complex Peripheral Interventions 14.3 Peripheral Thrombectomy & Thrombolysis
15 Structural Heart Interventions
15.1 Nonvalvular Structural Therapies 15.2 Percutaneous Valve Interventions
16 Chapter 16: Emergency Clinical Presentations & Equipment
16.1 STEMI, Cardiogenic Shock & Pulmonary Edema 16.2 Stroke & Neurologic Emergencies in the Lab 16.3 Emergency Equipment Operation
17 Intraprocedural Complications
17.1 Coronary Interventional Complications 17.2 Peripheral & Structural Complications
18 Post-Procedural Activities
18.1 Arterial & Venous Hemostasis 18.2 Access-Site Complications 18.3 Patient Education, Reporting & Transfer of Care
9.1 Anticipating Pharmacologic Needs
Key Takeaways Explain This Topic AI
RCIS Task 12 requires anticipating medications from procedure type, access route, allergies, renal function, and institutional protocol before the operator requests them
Diagnostic cath commonly uses 2,000–5,000 units IV heparin (or ~50 U/kg) with ACT targets around 200–250 seconds; PCI uses 70–100 U/kg with higher ACT goals
Radial cases anticipate spasmolytic cocktails (verapamil ± nitroglycerin) and heparin to reduce radial artery occlusion even during diagnostic studies
FFR cases require staged adenosine hyperemia with atropine and pacing support available; adenosine has an ultra-short half-life (~10 seconds)
Review antiplatelet and anticoagulant history (P2Y12 loads, DOACs, HIT) before vascular access and stage emergency reversal/pressor drugs at the bedside
Last updated: July 2026
9.1 Anticipating Pharmacologic Needs
Quick Answer: RCIS Task 12 expects you to anticipate medications before the operator asks—based on procedure type, access route, hemodynamics, renal function, allergies, and institutional protocol. Pre-stage anticoagulation , antiplatelet support, vasodilators , antiarrhythmics , contrast prep, and resuscitation drugs so delays never compromise the patient or the case.
Pharmacology in the cath lab is not pharmacy trivia—it is procedural choreography . The invasive specialist who reads the schedule, reviews the chart, and lines up the right syringes before the patient enters the room prevents spasm during radial access, thrombus during long PCI, hypotension during sedation, and contrast nephropathy in renal impairment. CCI Domain B (diagnostic and interventional support) weights medication anticipation heavily because delays in anticoagulation, spasm treatment, or reversal agents directly affect outcomes.
RCIS Scope: Anticipate, Prepare, Communicate
Your role is support , not independent prescribing. You:
Review the medication list, allergies (especially iodinated contrast , heparin , protamine , latex , chlorhexidine ), and relevant labs (creatinine/eGFR, potassium, INR, platelet count, hemoglobin).
Stage commonly used agents per protocol before vascular access.
Calculate or verify weight-based doses when the operator orders them (heparin bolus, protamine, amiodarone load).
Notify the operator of contraindications, recent P2Y12 loads, anticoagulant use, or renal dosing concerns.
Document times, doses, routes, and responses per institutional policy.
When an item asks what you should do before the procedure starts, the best answer usually involves checking allergies and renal function and having emergency medications immediately available —not waiting until a complication occurs.
Procedure-Based Anticipation Matrix
Clinical scenario Medications commonly anticipated RCIS preparation notes
Diagnostic coronary angiography IV unfractionated heparin (UFH) (often 2,000–5,000 units or ~50 U/kg after access); radial spasm cocktail (verapamil/diltiazem ± nitroglycerin intra-arterially) Lower ACT target (~ 200–250 sec ) than PCI; still anticoagulate for radial to reduce radial artery occlusion (RAO)
PCI / ACS UFH 70–100 U/kg (or bivalirudin per protocol); P2Y12 loading (ticagrelor/prasugrel/clopidogrel per plan); GP IIb/IIIa if ordered; intracoronary nitroglycerin for sizing/spasm Target ACT 250–300 sec with GP IIb/IIIa; 300+ sec without; confirm aspirin given unless contraindicated
FFR/iFR assessment Adenosine IV or IC hyperemia (FFR); atropine available for prolonged AV block/bradycardia with adenosine Stage flushes , stopcock , and ECG monitoring before hyperemia; know half-life ~10 sec for adenosine
Structural / transseptal UFH to ACT >250 sec (often 250–350) after LA access; reversal plan Some centers heparinize only after successful puncture—know your lab protocol
Sedation cases Midazolam/fentanyl (or propofol where credentialed); flumazenal/naloxone at bedside Monitor SpO₂ , EtCO₂ if available, blood pressure; anticipate hypotension and respiratory depression
Renal impairment / contrast risk IV hydration per protocol; minimize contrast volume; hold metformin per policy Anticipate N-acetylcysteine only if your institution uses it—follow written protocol
Contrast allergy / premedication Prednisone + diphenhydramine (or institutional H1/H2 block + steroid regimen) when ordered Confirm premed completed before contrast; still have epinephrine ready
Weight-Based Doses You Must Pre-Calculate
Agent Typical cath lab dosing When to calculate early
UFH bolus 70–100 U/kg IV for PCI Before large patients or pediatric-adjacent weights—verify with dual nurse check
Protamine 1 mg per 100 units UFH given in last ~60 min (max ~50 mg); slower infusion if high dose After prolonged cases or when ACT remains elevated at closure
Amiodarone 150 mg IV over 10 min for VT/VF (then infusion per ACLS) VT during PCI—have drawn before high-risk lesions
Atropine 0.5–1 mg IV (repeat to 3 mg) for symptomatic bradycardia Before adenosine , carotid sinus manipulation, or temporary pacing insertion
Epinephrine / norepinephrine / phenylephrine Push-dose pressors per ACLS or institutional chart Any unstable hemodynamics, anaphylaxis to contrast, or profound sedation effect
Always use the patient's actual weight from the record—not guess from appearance—and confirm units (heparin is in units , not mg).
Access-Route and Spasm Anticipation
Radial access demands more proactive pharmacology than femoral in many labs:
Intra-arterial spasmolytics (verapamil 2.5–5 mg, nitroglycerin 100–200 mcg) are often given prophylactically or at first resistance.
UFH after wire/sheath placement reduces RAO even during diagnostic cases.
Analgesia (local lidocaine, systemic fentanyl if sedated) reduces sympathetically driven spasm.
Femoral access still requires heparin for diagnostic and interventional cases, but spasm is less prominent—anticipate closure device needs and ACT before sheath pull (~ 150–180 sec or per protocol).
Antiplatelet and Anticoagulant History
Before the case, clarify:
Finding Anticipation action
Recent P2Y12 load (<24–72 h depending on agent) Confirm with operator—may affect timing of surgery elsewhere or bleeding risk
DOAC (apixaban, rivaroxaban, etc.) Operator decides hold vs continue; stage blood products if high bleeding risk
- Warfarin with elevated INR May delay elective case; have vitamin K/PCC plan only per physician order
- HIT history No heparin —anticipate bivalirudin or argatroban and notify pharmacy early
- Thrombocytopenia Confirm platelet threshold for procedure; stage platelet transfusion if ordered
- Contrast and Renal Protection
Iodinated contrast media are not "just fluids"—they are pharmacologically active osmolar loads. Anticipate:
Hydration (normal saline often 1–1.5 mL/kg/h before and after per protocol).
Contrast volume tracking —know cumulative mL and mL/kg especially in CKD, diabetes, heart failure, and repeat studies.
Hold nephrotoxic drugs (metformin, NSAIDs) per policy after the procedure.
Low-osmolar or iso-osmolar agents per formulary—still require allergy screening.
Emergency Trays and "Never Hunt" Drugs
Every occupied cath lab should have immediately reachable :
- Atropine , epinephrine , calcium chloride (if using)
- Amiodarone / lidocaine per ACLS
- Nitroglycerin (IV and IC syringes)
- Adenosine (if lab performs FFR or SVT termination)
- Flumazenil / naloxone when sedation used
- Dextrose / glucagon for hypoglycemia in diabetics
- Diphenhydramine / methylprednisolone / epinephrine for anaphylaxis
RCIS items often pair anticipation with sterile technique and Universal Protocol —the medication plan is part of the time-out when high-risk drugs (anticoagulation, thrombolytics, prolonged sedation) are expected.
- Communication Checklist Before First Contrast Injection
- Allergies and premedication status confirmed with team
- Anticoagulation plan stated (agent, target ACT, reversal available)
- Spasm and sedation drugs drawn or verified on tray
- Weight documented for weight-based boluses
- Renal risk mitigation (hydration, volume limit) discussed
- Emergency pressors and antiarrhythmics within arm's reach
Anticipating pharmacologic needs is how an RCIS candidate proves intra-procedural readiness —the same readiness CCI tests when it asks what you prepare before adenosine, before PCI heparin, or before contrast in a patient with eGFR 28 mL/min/1.73 m² .